Hints and tips:
Related Special Reports
...The Mainz-based pharmaceuticals producer will on Monday face its first German court hearing over the claims in a case brought on behalf of a middle-aged medical worker....
...The Russian Direct Investment Fund, the Kremlin’s state wealth fund that has financed the Gamaleya Institute’s Sputnik V vaccine, declined to comment on the Mexico trials but said approval by national healthcare...
...Dubai’s health authority started a separate vaccination campaign with Pfizer, later adding Oxford/AstraZeneca and Sputnik V....
...Adenovirus-based vaccines, such as Gamaleya’s Sputnik V, Oxford-AstraZeneca’s and Johnson & Johnson’s, for example, are limited by how much information they can hold and what the vaccines can be instructed...
...The makers of Russia’s Sputnik V have said it was “more efficient against the Delta variant of coronavirus . . . than any other vaccine that published results on this strain so far”, but provided no evidence...
...A study in the medical journal The Lancet last month found Sputnik V to be effective, but Vucic acknowledged that he “took a political risk” in deploying Sinopharm’s jab, for which headline figures only...
...Austria is in late-stage negotiations with Russia to acquire 1m doses of the Sputnik V vaccine by mid-June, even though the jab has not yet been approved for use by the EU medical regulator....
...Dr VK Paul, head of India’s vaccine strategy task force, said New Delhi hoped drugmakers such as Pfizer and Moderna would bring their vaccines to India “as soon as possible”....
...But he said he was confident that all adults over the age of 40 would be vaccinated by the end of June, thanks in part to doses from BioNTech/Pfizer and a possible purchase of Russia’s Sputnik V vaccine....
...Solid growth in the final quarter of the year left output just 1 per cent below the same period in 2019, highlighting the speed of the bounce back from last year’s downturn, and suggesting a “V-shaped” recovery...
...Inoculation locations are also being expanded to companies with their own medical facilities....
...Last week Hungary became the first EU country to start administering China’s Sinopharm vaccine, in addition to Russia’s Sputnik V and jabs developed by BioNTech/Pfizer, Moderna and Oxford/AstraZeneca....
...Hungary has ordered doses of the BioNTech/Pfizer, Moderna and Oxford/AstraZeneca vaccines via the EU but is the only member of the bloc to have also approved the Sinopharm and Russia-made Sputnik V vaccines...
...The EMA is conducting a rolling review of Sputnik V but has yet to authorise it for use across the bloc....
...Faced with no BioNTech/Pfizer deliveries until February 15, López Obrador insisted the pause was to free up vaccines for poor countries — a global call for which he claims credit....
...Dubai, which operates its own health authority, has also been administering the Pfizer and Oxford/AstraZeneca jabs. This month, the Russian Sputnik V was also offered....
...“Together with Pfizer, we are also working with various organisations to support the supply of vaccines to populations worldwide....
...The Haute Autorité de Santé, a panel of medical experts which advises the government, has said they should be given booster shots from BioNTech/Pfizer or Moderna....
...Russia’s healthcare watchdog has said that it has not detected any cases of blood clots arising from the use of the country’s Sputnik V vaccine....
...The theocratic state, which is already immunising medical staff with the Russian jab, says that it is....
...They can speed up approval and marketing significantly, especially when there is high unmet medical need....
...s Sputnik V jab....
...Russia’s Sputnik V jab carries deliberate cold war echoes....
...When factory worker Viktoria Marchenko fell ill with Covid-19 this month, the surge in cases in her hometown of Gatchina outside St Petersburg meant she had to fight for days to get adequate medical attention...
...Brazil’s health regulator on Saturday requested further data on Russia’s Sputnik V vaccine, after finding that minimum requirements had not been met in an application for emergency use submitted by a local...
International Edition